1 Presentation to NIH Scientific Management Review Board October 24, 2013 Concepcion R. Nierras, Ph.D. Assistant Vice President, International Partnerships,

Slides:



Advertisements
Similar presentations
Cancer Research UK strategy and funding Simon Vincent.
Advertisements

Miami CTSI--Culturalized Health Sciences for a Healthier South Florida! Clinical & Translational Science Institutes The U.S.A. launches an initiative to.
West Midlands Academic Health Science Network
West Midlands Academic Health Science Network
Excellence with Impact Declan Mulkeen January 2011.
Embedding Public Engagement Sophie Duncan and Paul Manners National Co-ordinating Centre for Public Engagement Funded by the UK Funding Councils, Research.
Engaging Patients and Other Stakeholders in Clinical Research
European Innovation for Active and Healthy Ageing
Research & Innovation Evolution from IMI1 to IMI2: challenges ahead Elmar Nimmesgern, PhD DG Research & Innovation 1.
Prize4Life: Inducement Prizes for ALS (Lou Gehrig’s Disease) Nicole Szlezak Member, Board of Directors Prize4Life.
Panel 13: Complex International Science, Technology and Innovation Partnerships: Lessons for Canada Pierre Bilodeau, PhD Chief Operating Officer ISTPCanada.
Public engagement and lifelong learning: old wine in a new bottle, or a blended malt? Paul Manners Director, National Co-ordinating Centre for Public Engagement.
The Key Role of Charities in Supporting Brain Research Marie Downes, MRCG Development Executive Brain Research in Ireland: Delivering on the Potential.
A global partnership to stop measles & rubella The Measles & Rubella Initiative: Preparing for the Next Decade Lisa Cairns, MD, MPH Sept 18, 2012 Washington,
Wellcome Trust/Australia/New Zealand International Collaborative Research Grants  Up to £12 million funding for Large grants to foster collaborative research.
JDRF Advocacy: Advancing Life- Changing Therapies
Irish Health Research: Collaboration and Partnership HSE Regional Library & Information Health Research Seminar Dr. Steevens’ Hospital 11th February 2011.
Global Plan to Stop TB Stop TB Partnership
A Report on Progress toward the Strategic Goals Presented to the Valencia District Board of Trustees on behalf of the College Planning Council.
The NIH Roadmap for Medical Research
Panel: Assessing the Value of Biomedical Research from public and patient perspectives NIH SMRB Meeting: October 24, 2013 Elaine K. Gallin, Ph.D. QE Philanthropic.
CURING T1D IS A GLOBAL, COORDINATED EFFORT 555 ACTIVE RESEARCH PROJECTS Note: JDRF research portfolio review September 2014.
THE ROLE OF ALZHEIMER ASSOCIATIONS IN CAMPAIGNING FOR CHANGE Marc Wortmann Alzheimer’s Disease International.
Supporting research and patient outreach for FacioScapuloHumeral Muscular Dystrophy (FSHD), one of the most common forms of muscular dystrophy. Progress.
November 21, Stutts Public Private Partnerships Barry Stutts November 21, 2002.
ACCELERATING CLINICAL AND TRANSLATIONAL RESEARCH
Affirming Our Commitment: “A Nation Free of Health and Health Care Disparities” J. Nadine Gracia, MD, MSCE Deputy Assistant Secretary for Minority Health.
Decision presented by the committee board members: Nicholas Mann & Katelyn Strasser FUTURE FUNDING FOR ALZHEIMER’S DISEASE October 14, 2014 MPH 543 Leadership.
Sue Hawkins Care Catering Services Manager Malnutrition Task Force Update Prevention and early intervention of malnutrition in later life.
1 The Lockheed Martin India Innovation Growth Program
THE ROLE OF STOP TB GHANA PARTNERSHIP Chief Austin A. Obiefuna National Coordinator SECRETARIAT CO-HOSTED BY AFRO GLOBAL ALLIANCE (GH) & GHANA SOCIETY.
How JDRF and the Social Media Played a Role in the Artificial Pancreas Campaign By: Stacia Kirby.
High-Impact Research to Change Lives. LEARNING OBJECTIVES Participants should leave energized by progress occurring in MS research, and should be able.
YMCA’s Diabetes Prevention Program
WHO Expert Working Group on R&D Financing Stop TB New Tools Working Groups Marcos Espinal Executive Secretary.
Turning TypeOne to The Plan for a World without T1D JDRF Translational Development: Partnering for Success.
>>> NPF OVERVIEW Kathleen Gallant National Psoriasis Foundation Trustee Secretary, IFPA National Psoriasis Foundation.
9th Dealing with Disasters International Conference (DwD 2015) Health Centered Disaster Risk Reduction: A New Agenda for a New Era Current Progress in.
1 Transforming JDRF Research. Impacting Lives. Julia L. Greenstein, PhD AVP Cure Therapies April 10, 2012.
ACCELERATING CLINICAL AND TRANSLATIONAL RESEARCH
NHS Health Check An opportunity to engage 15 million people to live well for longer Jamie Waterall NHS Health Check National Lead Public Health England.
 Our Mission The Canadian Cancer Society is a national, community-based organization of volunteers, whose mission is the.
D.Zucker Draft-EB09 Ethics & Academic Technology Transfer: Patients, Products and Public Trust Deborah Zucker, MD, PhD, Tufts Medical Center.
START global change SysTem for Analysis, Research & Training UNFCCC Expert Workshop on Monitoring and Evaluating Capacity Building in Developing Countries.
Partnership Structure KTP Funding Partners What is KTP? Give a man a fish and you feed him for a day. Teach him how to fish and you feed him for a lifetime…
Evaluation by Tiffany Kent
A baby will never know her mother’s touch How can you value this loss?
An Introduction to Genetic Alliance UK’s Work in Scotland Natalie Frankish – Development Officer for Scotland Event:Action Duchenne Scottish Conference.
Less Until None: A Plan for a World without T1D. 2 LESSUNTILNONE 2 JDRF’s Vision for the Future.
NIAMS Training Grant and Career Development Award Program Evaluation Presented by David Wofsy, M.D. Chairman Evaluation Working Group September 27, 2007.
Funding for collaborative projects Mark Littlewood Sensors & Instrumentation KTN.
The ARC — overview and opportunities (China) 16 November 2015 Presented by Mr Justin Withers Director, Policy and Integrity The Australian Research Council.
Do Price Controls Work?. Do price rice controls lower total spending: Physician fees example 2 * Fee for service Medicare beneficiaries. Source: Guterman,
A global partnership to stop measles & rubella 1 Measles & Rubella Initiative --Who We Are-- Stephen Cochi, MD, MPH Global Immunization Division Centers.
If we followed NICE guidelines and treated people with diabetes earlier, patients and the NHS would benefit from a reduction in complications, mortality.
© UEG Presentation by Towards more coordination in health research: a report on the UEG research symposium 16/11/2012 Michael Manns General Assembly.
Promoting physical activity for children and young people Schools and colleges Implementing NICE guidance 2009 NICE public health guidance 17.
Arnoldas Jurgutis, ITA NDPHS Primary Health Care Expert Group NDPHS EXPERT GROUP ON PRIMARY HEALTH CARE Activities in 2008 and discussions on possible.
MEP Interest Group on Brain, Mind and Pain
Non-communicable Diseases
GARD/NCD Action Plan & 2011 UN Summit on NCDs
What is €5 billion worth? Magda Gunn, IMI Scientific Project Manager.
Update from the National Institutes of Health (NIH)
Median submission gap, median approval time and percentage approved as expedited for new active substances (NASs) approved by six authorities:
But There is Hope and Progress…..
Jennifer McVean, MD September 23, 2010
the Image, Advocacy, and Impact of ISE Professionals Excel
Small Business Coalitions and Engagement
SARCOMA FOUNDATION OF AMERICA
Generating reliable evidence on the determinants of NCDs
Presentation transcript:

1 Presentation to NIH Scientific Management Review Board October 24, 2013 Concepcion R. Nierras, Ph.D. Assistant Vice President, International Partnerships, JDRF

2 JDRF Mission  Largest charitable supporter of T1D research in the world: USD 1.7 Billion invested in research over 40+ years  In 2012, USD 110 Million in direct support, in 18 countries  JDRF’s research mission: discover, develop & deliver drugs and devices that cure, better treat, and prevent T1D  Goal of transforming lives: - Improving outcomes - Reducing daily burdens - Preventing complications - Accelerating progress towards curing T1D

3 JDRF partners with all stakeholders JDRF partnerships:  National Institutes of Health  Australia NHMRC  Canada CIHR  EFSD  Singapore A*STAR  UK Wellcome Trust  Helmsley Charitable Trust Advocacy:  FDA  Australia TGA  EMEA  UK NICE

4 JDRF Research Strategy “ All T1D Stages and All Ages ” Functional 2nd Prevention Stop Autoimmunity Prevent Beta cell Loss 1st Prevention Prevent AutoimmunityPREVENTPREVENT CURECURE Stop Autoimmunity Preserve / Restore Beta cells Induce Immunoregulation TREAT / PREVENT Improve Glucose Control Prevent / Arrest / Reverse COMPLICATIONS From G Eisenbarth

5 How does your organization set goals? Volunteers are an important part of JDRF  JDRF Research Committee  T1D Voices Council Consultation with partners (govt, other foundations, and industry) Input from scientific experts (academia, govt and industry) Identifying gaps and opportunities Innovating mechanisms Research funding oversight

6 How does your organization assess whether it is meeting its goals? Evaluation of scientific progress Evaluation of program effectiveness Annual reporting includes evaluations/site visits Milestone-based payments for awards Partnerships:  Did it achieve its goals?  Was the science successful?  Are there new opportunities? Mechanisms: Training: did awardee make a career in diabetes research? How does this research contribute to understanding of disease?

7 Communicating results

Give generously to speed JDRF research to cure, better treat and prevent T1D Join a JDRF walk, ride, gala or other fund- raising event Volunteer at your local JDRF chapter Participate in clinical research You Make A Difference – Thank You! Learn more at: jdrf.org

Living with Diabetes: People with Type 1 Diabetes Are Living Longer, Healthier Lives Diabetes Duration at Death (years) Cumulative Survival Diagnosis Reduction in mortality compared to cohort 25 84% 80% 41% Figure adapted from Diabetes 55: , 2006